World

EU Commission to end AstraZeneca and J J vaccine contracts at expiry - paper

The EU Commission has decided not to renew COVID-19 vaccine contracts next year with companies such as Astrazeneca and Johnson & Johnson (J&J), Italian daily La Stampa reported on Wednesday citing a source from the Italian Health Ministry.

migrator

Updated:14th Apr, 2021 at 3:32 PM

Chennai

“The European Commission, in agreement with the leaders of many (EU) countries, has decided that the contracts with the companies that produce (viral vector) vaccines that are valid for the current year will not be renewed at their expiry,” the newspaper reported.

It added that Brussels would rather focus on COVID-19 vaccines using messenger RNA (mRNA) technology, such as Pfizer’s and Moderna’s.

The European Commission is seeking clarification from J&J about the company’s “completely unexpected” announcement of delays in COVID-19 vaccine deliveries to the EU, an EU official told Reuters on Tuesday.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

EU Commission to end AstraZeneca and J J vaccine contracts at expiry - paper

The EU Commission has decided not to renew COVID-19 vaccine contracts next year with companies such as Astrazeneca and Johnson &amp; Johnson (J&amp;J), Italian daily La Stampa reported on Wednesday citing a source from the Italian Health Ministry.

Also Read

2026 TN election | No sting in poll codes, districts cite no data: RTI document

2026 TN elections | Villivakkam independent candidate challenges Aadhav's nomination

2026 TN elections | Poll seizures scale all-time high, crosses Rs 900 crore

Chennai Corporation to renovate several night shelters after election

DT Next Constituency Watch | Gobichettipalayam: Agonising shift from agri to industry takes toll on lifeline Bhavani

The EU Commission has decided not to renew COVID-19 vaccine contracts next year with companies such as Astrazeneca and Johnson & Johnson (J&J), Italian daily La Stampa reported on Wednesday citing a source from the Italian Health Ministry.